Conferences  >  Medicine & Healthcare  >  Pharmacology and Drug Development

Phone: [6314854226];     Email: account@bocsci.com

MDPI

The IECV 2024 invites researchers from academia, as well as vaccine practitioners, to contribute original findings, novel ideas, scientific concepts, and new technologies and experiences to deal with immunology mechanisms, animal models for immunologic diseases, viral immunology, immunopathogenesis, vaccine development and efficacy evaluation, immune responses to vaccines, vaccine technology, vaccine vectors, adjuvants, and immunomodulators.

Email: iecv2024@mdpi.com

Immunology Mechanisms, Animal Models for Immunologic Diseases, Viral Immunology, Immunopathogenesis, Vaccine Development and Efficacy Evaluation, Immune Responses to Vaccines, Vaccine Technology, Vaccine Vectors Adjuvants and Immunomodulators

CHI

Drug Discovery Chemistry is a dynamic conference and networking event for drug discovery scientists working in pharma, biotech, and academia. One of the few events that reflects the new cross-functional and collaborative nature of drug discovery, our speakers and attendees are comprised primarily of pharma and biotech scientists, as well as key academic thought leaders working in translational research. Discussions of chemical tools and approaches to meet the practical (not theoretical) challenges of drug discovery are front and center. Speakers from industry include: Amgen, Astex Pharmaceuticals, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Chugai Pharmaceutical, Genentech, GSK, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, UCB Pharma, and more.

Phone: [781.972.5400];     Email: chi@healthtech.com

Virtue Insight

Virtue Insight is proud to announce that 19th Annual Biosimilars Congregation 2024 happening on 11th December 2024, Hotel Kohinoor Continental, Mumbai, India.

biosimilars, Biopharmaceuticals, Biotherapeutics, Follow on Biologics, Follow on Proteins, Biologics, Biotechnology, Bio generics, Legal Affairs, Intellectual Property

Pharma Market Research Conference

The Pharma Market Research Conference (February 5-6, 2025, New Jersey) is the best and largest industry assembly of market research executives in pharma, biotech, medical devices & diagnostics for 15+ years. This prestigious event brings together the industry’s top thought leaders and creates an environment of new ideas, relationships and perspectives. The Pharma Market Research Conference is the key to uncovering knowledge and developing new business relationships. Attendees will walk away with invaluable information, integrated connections, and countless business opportunities.

Event Organizer;     Email: ross@pharmamarketresearchconference.com

FDAMap

Starting or managing a clinical trial often feels like navigating a maze—from regulatory hurdles, site management, and patient recruitment to data accuracy, budget constraints, and compliance. These challenges are real, but smart trials offer breakthrough solutions by transforming each stage of your trial into an efficient, seamless experience. Imagine trials that are faster, safer, and easier to manage! With AI-driven recruitment, remote patient monitoring, and real-time data accuracy, smart trials are revolutionizing the industry.

FDA, Smart Clinical Trials, Clinical Trials, Clinical Study, Clinical Research, Clinical Development, FDA Regulations, FDA Compliance

Regulation in Medicine and Pharmacology,    Translational Medicine, Clinical Trials

The European Association for Cancer Research and Boehringer Ingelheim

We return to this topic for its second edition to focus on the basic and clinical aspects of the regulation of the Mitogen Activated Protein Kinase (MAPK) pathway, one of the most commonly mutated signalling pathways in human cancers. The programme will include new insights about the mechanisms of action of the new generation of pan-RAS inhibitors and rational combination therapies.

Email: christopher.iliffe@eacr.org

cancer research, oncology, MAPK pathway, small molecule inhibitors, intrinsic resistance, adaptive resistance, effective cancer therapy agents, pan-RAS inhibitors, gene regulation, target validation, drug development, clinical and translational opportunities, rational combination therapies, cross-resistance to immune modulators

Oncology,    Molecular Biology

Virtue Insight

This event will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. Take a chance and make it count by attending our event to network with your peers, exchange expertise and experiences, and arm yourself with the latest information to take your department to the next level. Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition.

Phone: [+44 2035093779];     Email: Kavitha@virtueinsight.co.in

Pharmacovigilance, regulatory affairs, Drug Safety, Drug Development, patient safety, RiskManagement, Pharmaceuticals, healthcare

Virtue Insight

This conference overviews and integrates the business and technical problems that pharmaceutical companies should be aware of in order to fight the major global problem of counterfeit medicines. In addition to discussion of the problems, this conference addresses serialization, track and trace analytical techniques scientists use to detect counterfeits and identifying solutions to the threat of counterfeit medical products. Be a part of this not to be missed event to know more on how to manage your serialization process in order to enhance your supply chain.

Phone: [+44 2035093779];     Email: Kavitha@virtueinsight.co.in

Anticounterfeiting, Serialisation, Pharmaceuticals, Counterfeit, Supply Chain, Track Trace, Drug regulatory, Packaging, labeling, Blockchain, ArtificialIntelligence, IoT

The European Association for Cancer Research

This meeting will explore the burgeoning field of cancer persister cells, a rare subset of cells which have emerged over the last decade as a significant factor in cancer treatment failure. Unlike resistance cells, which harbour genetic alterations enabling survival despite therapy, persister cells exhibit transient drug tolerance through reversible, non-mutational mechanisms. Our conference on this topic will bring together investigators from across the world to delve into molecular mechanisms, therapeutic targets, and emerging clinical implications of cancer persister cells, fostering collaboration and community-building in this pivotal and rapidly growing area of research.

Email: christopher.iliffe@eacr.org

cancer research, oncology, cancer persister cells, cancer resistant cells, non-genetic drug resistance, treatment response, treatment success, treatment failure, molecular mechanisms of resistance and persistence, novel study methodologies, targeting vulnerabilities within persister cells, clinical implications and applications

Oncology,    Molecular Biology

pagesconferences

International Conference on Pharmacovigilance and Regulatory Affairs (ICPRA-2025), a premier event focusing on the latest developments in the field of Pharmacovigilance and Regulatory Affairs which is going to be held in Rome, Italy during March 24-26, 2025.

This Conference will bring together pharmacovigilance professionals, researchers, and experts from around the world to discuss the latest advancements in Pharmacovigilance and Regulatory Affairs. Join us for a day of education, networking, and knowledge exchange. This event will provide a valuable opportunity for the attendees to learn from each other’s work, exchange ideas, create networks and build collaborations.

Phone: [910033064];     Email: icpra2025@pagesconferences.org

Pharmacovigilance Drug safety Drug Surveillance Pharmacology